Last reviewed · How we verify

NCT04560140

Promoting Community Reintegration for Young Adults With Stroke

Recruiting now NA Last updated 15 April 2024
What this trial tests

NA trial testing Narrative and Skills-building Intervention in Stroke in 208 participants. Currently enrolling.

Timeline
1 September 2021
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorChinese University of Hong Kong
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment208
Start date1 September 2021
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 18 to 64, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will investigate the effects of a Narrative and Skills-building Intervention on young stroke survivors' community reintegration and psychosocial outcomes. A randomised controlled trial will be conducted. This is a novel trial to test the short and long-term effects of a theory-based intervention on young stroke survivors' community reintegration.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Promoting community reintegration using narratives and skills building for young adults with stroke: a protocol for a randomised controlled trial.
    Lo SHS, Chau JPC, Choi KC, Shum EWC, et al · · 2021 · cited 5× · PMID 33397316 · DOI 10.1186/s12883-020-02015-5

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04560140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing